Canada Pharmaceuticals and Healthcare Report Q2 2015

Business Monitor International
February 25, 2015
101 Pages - SKU: BMI5475637
Countries covered: Canada

Canada Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Supported by strong democratic institutions and a long history of stable political Leadership,Canada is home to the second largest pharmaceutical market in the Americas and one of the largest inworld. We believe that drugmakers will continue to realise considerable rewards, as sales of patentedpharmaceuticals settle into a trend of steady growth, which is only nominally affected by the particularlyslow penetration of generics. However, drugmakers will find their interests threatened by the potential for asharp correction in private consumption which has been made increasingly fragile by high household debt,a weaker Canadian dollar and expectations of tightening of credit conditions once the Bank of Canadabegins to raise interest rates.

Headline Expenditure Projections

Pharmaceuticals: CAD22.93bn (USD20.75bn) in 2014 to CAD23.62bn (USD19.68bn) in 2015; +3.0%in local currency terms and -5.2% in US dollar terms. Forecast revised upwards from Q115.

Healthcare: CAD211.92bn (USD191.85bn) in 2014 to CAD220.60bn (USD183.84bn) in 2015; +4.1% inlocal currency terms and -4.2% in US dollar terms. Forecast revised downwards from Q115.



More Prescription Drugs reports by Business Monitor International

Tanzania Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q2 2015BMI View: Tanzania's pharmaceutical market will continue to see growth with the continuing expansion ofthe country's National Health Insurance ...
Singapore Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Singapore Pharmaceuticals and Healthcare Report Q2 2015BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceuticalcompanies due to minimal levels of operational ...
Poland Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Poland Pharmaceuticals and Healthcare Report Q2 2015BMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; anynegative economic developments will have an ...
Peru Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Peru Pharmaceuticals and Healthcare Report Q2 2015BMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for qualitycontrol will continue to ...
See all reports like this >>

More Canada Prescription Drugs reports

Canada Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Canada Pharmaceuticals and Healthcare Report Q1 2015BMI View: Canada's epidemiological profile will continue to be attractive to manufacturers of medicinesfor non-communicable diseases. Despite the relatively ...
Pharmaceuticals in Canada by MarketLine
Pharmaceuticals in CanadaIntroductionPharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...
Canada Pharmaceutical Industry by Aruvian's R'search
Canada Pharmaceutical IndustryThe Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada ...
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022SummaryDuring the forecast period from 2012-2022, the growth of the UC market will be ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!